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List of key features
Developmental delay
Microcephaly
Dysmorphism
Congenital diaphragmatic hernia
Generalized epilepsy
Unilateral camptodactyly of fifth finger
Short clinical summary
The patient’s mother reported a twin pregnancy with
missed abortion of one of the twins around the sixth week
of gestation. Shortly before birth, a prenatal ultrasound
revealed a diaphragmatic hernia and microcephaly in the
remaining twin. The female patient was born at the 41st
week of gestation. Her birth weight was 2720g (P10) and
her body length was 50 cm (P50). Postpartal investigation
revealed congenital hip dysplasia. The diaphragmatic
hernia was operated upon at the age of 2 days. The body
length and weight consistently developed close to the 10th
centile, whereas the head circumference was constantly
below the third. The developmental milestones were
delayed (free walking at 18 months and first words at 2½
years). The first epileptic seizures occurred at the age of 3
months. The girl had generalized tonic–clonic seizures,
occasionally occurring in impressive clusters lasting 24–48h
as well as clusters of seizures with secondary generalization.
The electroencephalography showed nonspecific mono-
morphic generalized slow-wave activity with rare spikes.
The parents never observed febrile seizures but reported
seizures in connection with a sinking body temperature
after febrile infections. Genetic analysis revealed a normal
female karyotype of 46,XX and normal array comparative
genomic hybridization results.
On examination at the age of 11 years, the patient
measured 135 cm and weighed 31.5 kg (both P10–P25)
with a head circumference of 49.5 cm (P1, – 2.5 SD).
The dysmorphic features included a round face with
arched eyebrows, a short nose, upslanting palpebral
fissures, a smoothed philtrum, mild retrognathia, crowded
teeth, a flattened midface, clinodactyly of the fifth
fingers and camptodactyly of the fifth finger on the right
(Fig. 1a–c). There were no flexion deficits of the elbows.
The patient was the second daughter of healthy and
nonconsanguineous parents of Swiss origin. The family
history was unremarkable, apart from two spontaneous
abortions (at approximately the 12th and sixth weeks of
gestation) before the patient’s healthy elder sister.
Investigations
DNA samples of the patient and both parents were
isolated from peripheral blood leucocytes using routine
procedures. Molecular genetic analysis of 323 genes
involved in epileptogenesis using a targeted next genera-
tion sequencing (NGS) approach (epilepsy panel version
2) was performed as recently described (Lemke et al.,
2012). Validation of the patient’s mutation and analysis of
its parental origin was performed by classical Sanger
sequencing. We further evaluated the effect of the
detected mutation by different in-silico prediction tools
(MutationTaster, Human Splicing Finder) (Desmet et al.,
2009; Adzhubei et al., 2010; Schwarz et al., 2010).
Results
Within the 323 genes investigated by the NGS epilepsy
panel, we revealed 101 variants with a global minor allele
frequency of less than 5%. We disregarded the following:
(a) variants within the 50 or 30 untranslated region, (b)
intronic variants more than ±20 bp outside of the
common splice sites, (c) synonymous exonic variants
more than ±2 bp outside of the common splice sites and
(d) variants that were evaluated as being most probably
false positives/technical artefacts (e.g. variants present
only in forward or reverse reads, those at adjacent
positions and those present in <20% of reads).
Among the remaining 12 variants, four were novel to dbSNP
135 (http://www.ncbi.nlm.nih.gov/projects/SNP/) (Table 1). Ten
of these 12 variants were unlikely to be causative because of
two or more of the following reasons: (a) there was only one
heterozygous variant within a recessive gene, (b) the gene
was not suggestive of the patient’s phenotype and (c) the
reference sequence presented with the minor allele.
Two variants in SCN9A and SMC1A were novel to dbSNP
135 and the exome variant server (Seattle, Washington,
USA; evs.gs.washington.edu/EVS/) and remained with
unclear significance.
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Finally, the synonymous heterozygous splice variant SMC1A
c.1731G>A/p.E577E at the last position of exon 10 was
proven to be of de-novo origin and predicted to cause a
loss of the donor splice site motif. The heterozygous
variant SCN9A c.1154T>G/p.V385G within exon 9 was
predicted to be pathogenic as well but was inherited from
the healthy father. Thus, we evaluated the SCN9A variant
as a presumably rare polymorphism and the de-novo
SMC1A variant as the most likely causative, leading to
the diagnosis of cohesinopathy in our patient. Because of
the lack of further consent, additional mRNA studies could
not be performed to further support this conclusion.
Discussion
Retrospectively, the girl’s symptoms and facial gestalt are
compatible with mild Cornelia de Lange syndrome
(CdLS). However, we did not consider this diagnosis
initially, and thus did not primarily commence with direct
genetic testing of SMC1A. Unfortunately, this is a
frequent situation in clinical genetics, as symptoms and
features of a patient only rarely allow a concise and
correct diagnosis and often require considerable syndro-
matological knowledge. Hence, targeted NGS can release
clinicians from the prerequisite of a precise clinical
diagnosis before genetic testing.
Fig. 1
(a) The patient has a round face, arched eyebrows, short nose, upslanting palpebral fissures, smoothed philtrum and crowded teeth; (b) mild
retrognathia and a flattened midface and (c) clinodactyly of the fifth fingers and camptodactyly of the fifth finger on the right.
Table 1 List of detected variants
Gene Mutation
Change of amino
acid Functional class
ID dbSNP
135 Associated disorder Inheritance Evaluation
ALDH4A1 c.678+3G>A NA Intronic rs138788183 Hyperprolinaemia type II AR AF 0.6%
No second mutation
ALG12 c.768+17G>A NA Intronic rs145358718 CDG1G AR No second mutation
ALG6 C167+19G>C NA Intronic Novel CDG1C AR No second mutation
ASPM c.7737T>C p.Y2494H NS, coding rs964201 Microcephaly AR Reference has minor
allele
No second mutation
EIF2B1 c.615G>C p.D158H NS, coding Novel Leucoencephalopathy with vanishing
white matter
AR No second mutation
EIF2B4 c.704G>A p.A235T NS, coding rs41288829 Leucoencephalopathy with vanishing
white matter
AR AF>3%
No second mutation
LAMA2 c.9200–15C>A NA Intronic rs55776770 Merosin-deficient muscular dystrophy AR No second mutation
NRXN1 c.2745C>T p.P469S NS, coding rs78540316 Pitt–Hopkins-like syndrome AR No second mutation
PAX6 c.129+9G>A NA Intronic rs56139994 Aniridia AR/(AD) AF 4.2%
No second mutation
RELN c.5268C>G p.P1703R NS, coding rs2229860 Lissencephaly AR AF 1.7%
No second mutation
SCN9A c.1154T>G p.V385G NS, coding Novel Generalized epilepsy with febrile seizures
plus
AD Inherited paternally
SMC1A c.1731G>A p.E577E S, coding, splice
site
Novel Cornelia de Lange syndrome-2 XD De novo
All 12 detected variants within the targeted 323 genes that remained after the filtering procedure, 10 of which were unlikely to be causative are shown. Of the remaining
two variants, only SCM1A c.1731G>A appeared to be of de-novo origin and compatible with the girl’s phenotype.
AD, autosomal dominant; AF, allele frequency; AR, autosomal recessive; CDG, congenital disorder of glycosylation; NA, not applicable; NS, nonsynonymous;
S, synonymous; XD, X-linked dominant.
144 Clinical Dysmorphology 2013, Vol 22 No 4
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Most known SMC1A patients have been detected because
of their CdLS/CdLS-like phenotypes (Deardorff et al.,
2007). However, several patients lacking classical or
suggestive phenotypic features (Deardorff et al., 2007)
prove that the spectrum of SMC1A mutations might go
beyond the known CdLS-like phenotype. This is sup-
ported by the case of a recently described nonsyndromic,
autistic patient carrying a SMC3 mutation (Sanders et al.,
2012). Thus, a direct clinical diagnosis can be challenging
and the broader term ‘cohesinopathy’ might be more
adequate for this phenotypic spectrum than is CdLS.
The mutation c.1731G>A/p.E577E in our patient expands
the mutational spectrum of SMC1A to splice site mutations
and also represents the first exonic synonymous splice site
mutation observed in any human cohesinopathy.
The detected variant SCN9A p.V385G remains of unknown
significance. Because of paternal inheritance, it is unlikely
to be causative of the girl’s phenotype but might still
modify her generalized epilepsy (Singh et al., 2009).
Congenital diaphragmatic hernias have been described
occasionally in patients with ‘classic’ CdLS because of
NIPBL mutations (Fryns, 1987). However, Deardorff et al.
(2007) reported no diaphragmatic hernias nor other major
structural abnormalities in SMC1A (and SMC3) patients.
Our observation reveals that diaphragmatic hernias are
also part of the milder (non-NIPBL) cohesinopathies.
Finally, we demonstrate how NGS panel diagnostics
significantly facilitate mutation detection. Screening of
larger cohorts with less specific phenotypes might help
reveal the true phenotypic spectrum of many conditions,
not only of human cohesinopathies or epilepsies. As
shown in several cases, it will dramatically expand our
understanding of the genotype–phenotype correlations of
known (and yet unknown) disease-causing genes (Kousi
et al., 2012; Lemke et al., 2012).
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